Funded Tech Companies
Neurenati Therapeutics
Wondering who backed Neurenati Therapeutics? Genson Capital and private investors invested in this healthcare services company.
Company Overview
Company Name
Neurenati Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
630 René-Lévesque Blvd W. 20th floor
Montreal, Quebec, H3B 1S6
Canada
Montreal, Quebec, H3B 1S6
Canada
Phone
Website
Email Address
Company Background Information
Overview
Based in Montreal, Neurenati Therapeutics is a pioneering biotechnology company developing an innovative treatment for Hirschsprung disease. Nicolas Pilon, an expert in rare diseases, and Rodolphe Soret, a specialist in neuro-gastroenterology, have combined their expertise to develop an innovative treatment for Hirschsprung disease.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/29/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Maxime Ranger
Chief Scientific Officer
Nicolas Pilon
Co-Founder
Rodolphe Soret
Company Investors
Browse more funded tech companies:
Neurelis | Neurexis Therapeutics
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs